Amphotericin B: Polyene Antifungal Antibiotic for Advanced Fungal Infection Research

Executive Summary: Amphotericin B (SKU B1885) is an amphipathic polyene antifungal antibiotic produced by Streptomyces nodosus with a molecular weight of 924.08 and chemical formula C₄₇H₇₃NO₁₇ (APExBIO). It interacts selectively with ergosterol in fungal membranes, forming pores that disrupt cation and anion homeostasis and induce cell death (Shen et al., 2025). Amphotericin B exhibits potent antifungal activity (IC₅₀ 0.028–0.290 μg/mL) and has demonstrated efficacy against drug-resistant Candida albicans biofilms. It modulates immune signaling via TLR2 and CD14 pathways, activating NF-κB in macrophages and engineered HEK293 cells. The compound is a critical tool for research on fungal infection dynamics, immune response, and prion disease modeling.

Biological Rationale

Fungal infections pose major clinical challenges due to rising drug resistance, especially in Candida albicans biofilms, which are intrinsically tolerant to conventional antifungal agents (Shen et al., 2025). Existing antifungal classes—azoles, echinocandins, and polyenes—are limited by resistance mechanisms and toxicity profiles. Amphotericin B, a polyene antifungal antibiotic, remains a research standard due to its unique sterol-targeting action and broad-spectrum efficacy. Its amphipathic structure enables selective disruption of fungal membranes. Understanding its biological effects informs both basic membrane biology and translational approaches to drug-resistant fungal infections. These themes extend and update the mechanistic focus presented in "Amphotericin B in Translational Research: Mechanistic Insights", by integrating new data on biofilm resistance and immune signaling.

Mechanism of Action of Amphotericin B

Amphotericin B binds to ergosterol, a key sterol in fungal membranes, leading to the formation of aqueous pores. These pores increase membrane permeability to small cations (Na⁺, K⁺, H⁺) and anions, disrupting ion gradients and causing fungal cell death (APExBIO). The compound can also interact with cholesterol in mammalian membranes, contributing to its noted cytotoxicity. In vitro studies demonstrate that Amphotericin B activates TLR2 and CD14-dependent NF-κB signaling in macrophages and HEK293 cells, inducing cytokine release and immune activation. This dual activity—membrane disruption and immune modulation—differentiates Amphotericin B from many other antifungal agents. Its action on biofilms and prion-infected tissues is under continued investigation, broadening its relevance beyond conventional antifungal therapy and clarifying points raised in "Amphotericin B in the Age of Biofilm Resistance".

Evidence & Benchmarks

• Amphotericin B displays potent antifungal activity with an IC₅₀ range of 0.028–0.290 μg/mL in Candida albicans and related models (APExBIO).
• It disrupts biofilm formation and increases susceptibility of Candida albicans to antifungal agents, particularly when autophagy is inhibited (Shen et al., 2025).
• Amphotericin B induces NF-κB activation and inflammatory cytokine release via TLR2/CD14 in macrophages and engineered HEK293 cells (APExBIO).
• In animal models of transmissible spongiform encephalopathies (e.g., hamster scrapie), Amphotericin B prolongs survival and reduces prion protein (PrP^Sc) accumulation (APExBIO).
• Stock solutions are stable at ≥46.2 mg/mL in DMSO at -20°C, but Amphotericin B is insoluble in ethanol and water (APExBIO).

Applications, Limits & Misconceptions

Applications:

• Fungal infection research: Particularly in drug-resistant C. albicans biofilms and planktonic cells.
• Immune signaling: Elucidation of TLR2 and CD14-mediated pathways, NF-κB activation, and cytokine responses.
• Prion disease research: Assessment of anti-prion efficacy and neuroprotection in vivo.
• Membrane biology: Dissection of sterol-dependent membrane permeability and homeostasis.

Limits: Amphotericin B exhibits notable toxicity due to cholesterol binding in mammalian cells, restricting its use to research contexts. It is not recommended for direct clinical use outside of controlled research settings.

Common Pitfalls or Misconceptions

• Assuming water or ethanol solubility: Amphotericin B is insoluble in both and must be dissolved in DMSO (≥46.2 mg/mL).
• Long-term storage of stock solutions: Solutions degrade upon repeated freeze-thaw; prepare fresh aliquots.
• Universal efficacy against all fungal biofilms: Some biofilm models with activated autophagy may show reduced susceptibility (Shen et al., 2025).
• Assuming mammalian cell safety: Amphotericin B can disrupt cholesterol-rich membranes, causing cytotoxicity at higher concentrations.
• Overgeneralizing immune activation: Cytokine induction is context-dependent and varies by cell type and receptor expression.

Workflow Integration & Parameters

Amphotericin B is supplied as a lyophilized powder by APExBIO (product details). Stock solutions should be prepared in DMSO at concentrations ≥46.2 mg/mL and stored at -20°C. For cell-based antifungal assays, typical working concentrations range from 1 to 4 μg/mL. Freshly prepared solutions are recommended for reproducibility. In immune signaling studies, dose-response and time-course experiments are essential to characterize cytokine release and pathway activation. For prion disease models, dosing regimens must be adapted to animal weight and route of administration. For troubleshooting and advanced workflows, see "Amphotericin B: Advanced Workflows in Fungal Infection Research", which focuses on optimized protocols and troubleshooting, whereas this article emphasizes mechanistic and translational updates.

Conclusion & Outlook

Amphotericin B remains foundational for fungal infection research, immune signaling analysis, and prion disease modeling. Its dual targeting of fungal membrane sterols and immune receptors makes it uniquely valuable for dissecting resistance mechanisms and host-pathogen interactions. Researchers should employ rigorous controls, attention to solubility and storage, and context-specific dosing to maximize reproducibility. Further research into autophagy-mediated biofilm resistance and immune modulation will extend the utility of Amphotericin B in the laboratory. For detailed product information and experimental guidance, refer to the Amphotericin B (SKU B1885) page at APExBIO.